These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25393939)

  • 1. Antiretroviral therapy in HIV-infected elite controllers: impact on gut immunology, microbial translocation, and biomarkers of serious non-AIDS conditions.
    Kim CJ; Kovacs C; Chun TW; Kandel G; Osborne BJ; Huibner S; Shahabi K; Yue FY; Benko E; Ostowski M; Kaul R
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):514-8. PubMed ID: 25393939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection.
    Mehraj V; Ramendra R; Isnard S; Dupuy FP; Lebouché B; Costiniuk C; Thomas R; Szabo J; Baril JG; Trottier B; Coté P; LeBlanc R; Durand M; Chartrand-Lefebvre C; Kema I; Zhang Y; Finkelman M; Tremblay C; Routy JP
    Front Immunol; 2019; 10():289. PubMed ID: 30846990
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma Levels of C-Type Lectin REG3α and Gut Damage in People With Human Immunodeficiency Virus.
    Isnard S; Ramendra R; Dupuy FP; Lin J; Fombuena B; Kokinov N; Kema I; Jenabian MA; Lebouché B; Costiniuk CT; Ancuta P; Bernard NF; Silverman MS; Lakatos PL; Durand M; Tremblay C; Routy JP;
    J Infect Dis; 2020 Jan; 221(1):110-121. PubMed ID: 31504638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART.
    Stiksrud B; Nowak P; Nwosu FC; Kvale D; Thalme A; Sonnerborg A; Ueland PM; Holm K; Birkeland SE; Dahm AE; Sandset PM; Rudi K; Hov JR; Dyrhol-Riise AM; Trøseid M
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):329-37. PubMed ID: 26258571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery.
    Hoffman RM; Leister E; Kacanek D; Shapiro DE; Read JS; Bryson Y; Currier JS
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):593-601. PubMed ID: 23714738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam.
    Bi X; Ishizaki A; Nguyen LV; Matsuda K; Pham HV; Phan CT; Ogata K; Giang TT; Phung TT; Nguyen TT; Tokoro M; Pham AN; Khu DT; Ichimura H
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers.
    Kim CJ; Rousseau R; Huibner S; Kovacs C; Benko E; Shahabi K; Kandel G; Ostrowski M; Kaul R
    AIDS; 2017 Jul; 31(11):1529-1534. PubMed ID: 28463882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events.
    Freiberg MS; Bebu I; Tracy R; So-Armah K; Okulicz J; Ganesan A; Armstrong A; O'Bryan T; Rimland D; Justice AC; Agan BK;
    PLoS One; 2016; 11(4):e0152588. PubMed ID: 27088215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for innate immune system activation in HIV type 1-infected elite controllers.
    Krishnan S; Wilson EM; Sheikh V; Rupert A; Mendoza D; Yang J; Lempicki R; Migueles SA; Sereti I
    J Infect Dis; 2014 Mar; 209(6):931-9. PubMed ID: 24185941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammation in a long-term cohort of HIV-infected patients according to the normalization of the CD4:CD8 ratio.
    Saracino A; Bruno G; Scudeller L; Volpe A; Caricato P; Ladisa N; Monno L; Angarano G
    AIDS Res Hum Retroviruses; 2014 Dec; 30(12):1178-84. PubMed ID: 25360575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Th17 cells expressing β7 intestinal homing receptor in recent and chronic HIV infections.
    Márquez-Coello M; Montes-de-Oca Arjona M; Fernández-Gutiérrez Del Álamo C; Ruiz-Sánchez C; Girón-González JA
    Clin Exp Immunol; 2018 Dec; 194(3):350-360. PubMed ID: 30101536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.
    Boulware DR; Hullsiek KH; Puronen CE; Rupert A; Baker JV; French MA; Bohjanen PR; Novak RM; Neaton JD; Sereti I;
    J Infect Dis; 2011 Jun; 203(11):1637-46. PubMed ID: 21592994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection.
    Pérez-Santiago J; Gianella S; Massanella M; Spina CA; Karris MY; Var SR; Patel D; Jordan PS; Young JA; Little SJ; Richman DD; Smith DM
    AIDS; 2013 Jul; 27(12):1921-31. PubMed ID: 24180001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression.
    Castillo-Mancilla JR; Morrow M; Boum Y; Byakwaga H; Haberer JE; Martin JN; Bangsberg D; Mawhinney S; Musinguzi N; Huang Y; Tracy RP; Burdo TH; Williams K; Muzzora C; Hunt PW; Siedner MJ
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):507-513. PubMed ID: 29346185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.
    Grund B; Baker JV; Deeks SG; Wolfson J; Wentworth D; Cozzi-Lepri A; Cohen CJ; Phillips A; Lundgren JD; Neaton JD;
    PLoS One; 2016; 11(5):e0155100. PubMed ID: 27171281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.
    Macatangay BJ; Yang M; Sun X; Morton J; De Gruttola V; Little S; Hogan C; Rinaldo CR;
    J Acquir Immune Defic Syndr; 2017 May; 75(1):137-141. PubMed ID: 28198712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy.
    Vesterbacka J; Barqasho B; Häggblom A; Nowak P
    AIDS Res Hum Retroviruses; 2015 Aug; 31(8):830-6. PubMed ID: 26059763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens.
    Buckner CM; Kardava L; Zhang X; Gittens K; Justement JS; Kovacs C; McDermott AB; Li Y; Sajadi MM; Chun TW; Fauci AS; Moir S
    J Infect Dis; 2016 Aug; 214(3):390-8. PubMed ID: 27122593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.